Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has found that bile acid diversion in Roux-en-Y gastric bypass (RYGB) reduces ...

A new hydrogel-based platform to preserve live patient-derived tumor tissues in the lab could pave the way for faster, more ...

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal ...

Colon cancer, also known as colorectal cancer, is a type of cancer that develops in the colon or rectum, the last part of the large intestine. It often starts as small, noncancerous clumps of cells ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

Researchers at the University of California Davis Comprehensive Cancer Center have uncovered an evolutionary change that may ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...